Emmessar Biotech & Nutrition Ltd Financial Ratios
524768 · Chemicals · Current price
P/E ratio
27.7x
P/B ratio
1.5x
ROE
5.6%
ROCE
12.6%
Debt / Equity
0.00
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 27.7x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 1.5x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 5.6% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 12.6% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.00 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Emmessar Biotech & Nutrition Ltd's latest numbers.
Emmessar Biotech & Nutrition Ltd profitability
Emmessar Biotech & Nutrition Ltd generates a return on equity of 5.6% and a return on capital employed of 12.6%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.00 and a P/E of 27.7x, Emmessar Biotech & Nutrition Ltd is conservatively financed. Our overall business-quality score for the company is 4.7 / 10.
Understand the ratios
More on Emmessar Biotech & Nutrition Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.